Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZZ) Current Leases (2021 - 2025)

Historic Current Leases for Core Scientific (CORZZ) over the last 5 years, with Q1 2025 value amounting to $10.0 million.

  • Core Scientific's Current Leases rose 23074.88% to $10.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $10.0 million, marking a year-over-year increase of 23074.88%. This contributed to the annual value of $10.0 million for FY2024, which is 4955.24% down from last year.
  • As of Q1 2025, Core Scientific's Current Leases stood at $10.0 million, which was up 23074.88% from $10.0 million recorded in Q4 2024.
  • In the past 5 years, Core Scientific's Current Leases ranged from a high of $73.0 million in Q3 2022 and a low of $423000.0 during Q2 2023
  • In the last 5 years, Core Scientific's Current Leases had a median value of $10.0 million in 2024 and averaged $17.3 million.
  • Within the past 5 years, the most significant YoY rise in Core Scientific's Current Leases was 247100.13% (2023), while the steepest drop was 9851.94% (2023).
  • Core Scientific's Current Leases (Quarter) stood at $28.5 million in 2021, then crashed by 97.3% to $769000.0 in 2022, then surged by 2471.0% to $19.8 million in 2023, then tumbled by 49.55% to $10.0 million in 2024, then rose by 0.08% to $10.0 million in 2025.
  • Its Current Leases was $10.0 million in Q1 2025, compared to $10.0 million in Q4 2024 and $7.5 million in Q3 2024.